BioSpace News Archive

Beactica Therapeutics, the Swedish drug discovery company, announced its participation in a Marie Skłodowska-Curie Innovative Training Network called UbiMotif.

BWX Technologies, Inc. announced that it plans to produce the medical radioisotope Germanium-68 with a focus on addressing a growing global demand for the product..

Applications For The Salix Gastrointestinal Health Scholars Program Will Be Accepted Beginning Nov. 1, 2019

NantHealth, Inc., a next-generation, evidence-based, personalized healthcare company, announced that it will report financial results for its 2019 third quarter on Thursday, November 7, 2019, after market close.

Orchard Therapeutics announced that the company will host a conference call and live webcast on Wednesday, November 6, 2019 at 4:30 p.m.

iCAD, Inc., a global medical technology leader providing innovative cancer detection and therapy solutions reported its financial and operating results for the three and nine months ended September 30, 2019.

Bristol-Myers Squibb Company announced the extension of the expiration date of the offers to exchange notes issued by Celgene Corporation for up to $19,850,000,000 aggregate principal amount of new notes to be issued by Bristol-Myers Squibb Company and cash and the related consent solicitations being made by Bristol-Myers Squibb on behalf of Celgene to adopt certain proposed amendments to the indentures governing the Celgene Notes.

Pooled efficacy and cardiovascular safety analyses from global Phase III program, and efficacy data from Phase III OLYMPUS and ROCKIES trials to be presented

Arbutus Biopharma Corporation (Nasdaq: ABUS), a Hepatitis B Virus (HBV) therapeutic solutions company, today announced that it has scheduled its third quarter financial results, conference call and webcast for Wednesday, November 6, 2019.

McKesson Corporation reported results for the second quarter ended September 30, 2019.